EL-715

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEL-715
Drug Alias NameEL-715
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsPsoriasisOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesElan Pharma International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElan Corp
Active IndicationsN/A
Inactive IndicationsPsoriasisOsteoporosis, Postmenopausal

Other Information

ATC CodeN/A
Related LinksN/A